80 related articles for article (PubMed ID: 16478697)
1. Staging of non-small cell lung cancer (NSCLC).
Rankin SC
Cancer Imaging; 2006 Jan; 6(1):1-3. PubMed ID: 16478697
[TBL] [Abstract][Full Text] [Related]
2. Preoperative intrathoracic lymph node staging in patients with non-small-cell lung cancer: accuracy of integrated positron emission tomography and computed tomography.
Billé A; Pelosi E; Skanjeti A; Arena V; Errico L; Borasio P; Mancini M; Ardissone F
Eur J Cardiothorac Surg; 2009 Sep; 36(3):440-5. PubMed ID: 19464906
[TBL] [Abstract][Full Text] [Related]
3. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.
Kauhanen SP; Komar G; Seppänen MP; Dean KI; Minn HR; Kajander SA; Rinta-Kiikka I; Alanen K; Borra RJ; Puolakkainen PA; Nuutila P; Ovaska JT
Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736
[TBL] [Abstract][Full Text] [Related]
4. Imaging of non-small cell lung cancer of the superior sulcus: part 2: initial staging and assessment of resectability and therapeutic response.
Bruzzi JF; Komaki R; Walsh GL; Truong MT; Gladish GW; Munden RF; Erasmus JJ
Radiographics; 2008; 28(2):561-72. PubMed ID: 18349458
[TBL] [Abstract][Full Text] [Related]
5. Preoperative mediastinal and hilar nodal staging with diffusion-weighted magnetic resonance imaging and fluorodeoxyglucose positron emission tomography/computed tomography in patients with non-small-cell lung cancer: which is better?
Wu LM; Xu JR; Gu HY; Hua J; Chen J; Zhang W; Haacke EM; Hu J
J Surg Res; 2012 Nov; 178(1):304-14. PubMed ID: 22541065
[TBL] [Abstract][Full Text] [Related]
6. Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography.
Lardinois D; Weder W; Hany TF; Kamel EM; Korom S; Seifert B; von Schulthess GK; Steinert HC
N Engl J Med; 2003 Jun; 348(25):2500-7. PubMed ID: 12815135
[TBL] [Abstract][Full Text] [Related]
7. Diffusion-weighted magnetic resonance imaging can be used in place of positron emission tomography for N staging of non-small cell lung cancer with fewer false-positive results.
Nomori H; Mori T; Ikeda K; Kawanaka K; Shiraishi S; Katahira K; Yamashita Y
J Thorac Cardiovasc Surg; 2008 Apr; 135(4):816-22. PubMed ID: 18374761
[TBL] [Abstract][Full Text] [Related]
8. Regional nodal staging with 18F-FDG PET-CT in non-small cell lung cancer: Additional diagnostic value of CT attenuation and dual-time-point imaging.
Li M; Wu N; Liu Y; Zheng R; Liang Y; Zhang W; Zhao P
Eur J Radiol; 2012 Aug; 81(8):1886-90. PubMed ID: 21511421
[TBL] [Abstract][Full Text] [Related]
9. CT, positron emission tomography, and MRI in staging lung cancer.
Erasmus JJ; Sabloff BS
Clin Chest Med; 2008 Mar; 29(1):39-57, v. PubMed ID: 18267183
[TBL] [Abstract][Full Text] [Related]
10. Towards a minimally invasive staging strategy in NSCLC: analysis of PET positive mediastinal lesions by EUS-FNA.
Annema JT; Hoekstra OS; Smit EF; Veseliç M; Versteegh MI; Rabe KF
Lung Cancer; 2004 Apr; 44(1):53-60. PubMed ID: 15013583
[TBL] [Abstract][Full Text] [Related]
11. Feasibility of [18F]FDG-PET and coregistered CT on clinical target volume definition of advanced non-small cell lung cancer.
Messa C; Ceresoli GL; Rizzo G; Artioli D; Cattaneo M; Castellone P; Gregorc V; Picchio M; Landoni C; Fazio F
Q J Nucl Med Mol Imaging; 2005 Sep; 49(3):259-66. PubMed ID: 16172572
[TBL] [Abstract][Full Text] [Related]
12. Lymph node involvement in T1 non-small-cell lung cancer: could glucose uptake and maximal diameter be predictive criteria?
Casiraghi M; Travaini LL; Maisonneuve P; Tessitore A; Brambilla D; Agoglia BG; Guarize J; Spaggiari L
Eur J Cardiothorac Surg; 2011 Apr; 39(4):e38-43. PubMed ID: 21242094
[TBL] [Abstract][Full Text] [Related]
13. [Comparison between PET(-FDG) and computed tomography in the staging of lung cancer. Consequences for operability in 94 patients].
Prévost A; Papathanassiou D; Jovenin N; Menéroux B; Cuif-Job A; Bruna-Muraille C; Domange-Testard A; Liehn JC
Rev Pneumol Clin; 2009 Dec; 65(6):341-9. PubMed ID: 19995654
[TBL] [Abstract][Full Text] [Related]
14. Coregistered whole body magnetic resonance imaging-positron emission tomography (MRI-PET) versus PET-computed tomography plus brain MRI in staging resectable lung cancer.
Parry PV; Engh JA
Neurosurgery; 2013 Dec; 73(6):N11-3. PubMed ID: 24257336
[No Abstract] [Full Text] [Related]
15. Advances in radiological staging of non-small cell lung cancer (NSCLC).
Rankin SC
Cancer Imaging; 2004 Feb; 4 Spec No A(Spec No A):S22-4. PubMed ID: 18215971
[TBL] [Abstract][Full Text] [Related]
16. [Role of imaging techniques in the TNM classification of non-small cell bronchogenic carcinoma].
Cano Alonso R; Herráiz Hidalgo L; Álvarez Moreno E; Paniagua Correa C; Martínez de Vega V
Radiologia; 2012; 54(4):306-20. PubMed ID: 22226376
[TBL] [Abstract][Full Text] [Related]
17. Preoperative imaging for metastasectomy.
Klippenstein DL; Lamonica DM
Surg Oncol Clin N Am; 2007 Jul; 16(3):471-92, vii. PubMed ID: 17606189
[TBL] [Abstract][Full Text] [Related]
18. [New procedures. Comprehensive staging of lung cancer by MRI].
Hintze C; Dinkel J; Biederer J; Heussel CP; Puderbach M
Radiologe; 2010 Aug; 50(8):699-705. PubMed ID: 20628723
[TBL] [Abstract][Full Text] [Related]
19. Pitfalls and limitations in non-small cell lung cancer staging.
Betancourt-Cuellar SL; Carter BW; Palacio D; Erasmus JJ
Semin Roentgenol; 2015 Jul; 50(3):175-82. PubMed ID: 26002237
[No Abstract] [Full Text] [Related]
20. Modern treatment of lung cancer: case 3. Non-metastatic bilateral F-18 fluorodeoxyglucose avid adrenal glands in non-small-cell lung cancer.
Costa DB; Parker JA; Schumer ST
J Clin Oncol; 2005 Oct; 23(30):7740-2. PubMed ID: 16234534
[No Abstract] [Full Text] [Related]
[Next] [New Search]
